| Hazard ratios | p |
---|---|---|
Clinical characteristics | Â | Â |
 Age (years) | 1.00 [CI 1.00–1.01] | 0.36 |
 Gender (male) | 1.25 [CI 0.88–1.76] | 0.20 |
 Cancer etiologies |  |  |
  Sarcoma | 0.91 [CI 0.61–1.37] | 0.65 |
  Lung | 1.45 [CI 0.95–2.21] | 0.08 |
  Genitourinary | 1.12 [CI 0.73–1.73] | 0.59 |
  Gastrointestinal | 1.56 [CI 0.96–2.54] | 0.07 |
  Skin/melanoma | 0.71 [CI 0.41–1.20] | 0.20 |
  Lymphoma | 0.40 [CI 0.19–0.86] | 0.02 |
  Endocrine | 0.62 [CI 0.31–1.22] | 0.16 |
 Cardiovascular risk factors |  |  |
  Hypertension | 0.98 [CI 0.70–1.35] | 0.86 |
  Hyperlipidemia | 1.00 [CI 0.70–1.44] | 0.99 |
  Diabetes mellitus | 0.87 [CI 0.52–1.46] | 0.59 |
  Smoking | 1.01 [CI 0.71–1.41] | 0.98 |
 Cardiopulmonary disease |  |  |
  Coronary artery disease | 1.36 [CI 0.84–2.21] | 0.21 |
  Atrial fibrillation/flutter | 1.16 [CI 0.74–1.82] | 0.52 |
  Pulmonary disease | 0.86 [CI 0.41–1.77] | 0.67 |
  Pulmonary hypertension | 1.33 [CI 0.86–2.06] | 0.20 |
Cardiac morphology | Â | Â |
 Left ventricle |  |  |
  Ejection fraction | 1.01 [CI 0.99–1.03] | 0.21 |
  Ejection fraction (< 50%) | 0.82 [CI 0.50–1.36] | 0.44 |
  End-diastolic volume | 1.00 [CI 0.99–1.00] | 0.06 |
  End-systolic volume | 0.99 [CI 0.99–1.00] | 0.07 |
 Right ventricle |  |  |
  Ejection fraction | 1.02 [CI 1.00–1.04] | 0.09 |
  Ejection fraction (< 50%) | 0.84 [CI 0.57–1.26] | 0.40 |
 CMET Lesion Characteristics |  |  |
  CMET (presence vs. absence)* | 1.64 [CI 1.17–2.29] | 0.004 |
 Anatomic properties |  |  |
  Lesion number | 1.67 [CI 1.31–2.12] |  < 0.001 |
  Multiple lesions | 1.94 [CI 1.23–3.06] | 0.004 |
  Lesion size (maximal diameter [per 10 cm]) | 1.11 [CI 0.53–2.33] | 0.79 |
  Lesion size (area [per 10 cm2]) | 0.99 [CI 0.85–1.15] | 0.88 |
  Intra-cavitary lesion | 1.27 [CI 0.81–1.97] | 0.30 |
 Tissue properties* |  |  |
  Heterogeneous enhancement | 1.97 [CI 1.23–3.15] | 0.005 |
  Diffuse enhancement | 1.36 [CI 0.84–2.21] | 0.21 |
 Adjusted multivariate model†|  |  |
  Lymphoma (cancer etiology) | 0.44 [CI 0.11–1.79] | 0.24 |
  Heterogeneous enhancement | 1.97 [CI 1.23–3.16] | 0.005 |